Cancer Research Education Grants Program (R25)
The Cancer Research Education Grants Program (CREGP) (R25) provides support for educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. Applications should propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. There are three CREGP Funding Opportunity Announcements (FOAs):
- CREGP–Curriculum or Methods Development (PAR-15-150): supports curriculum or methods development activities that have a high potential to improve biomedical, behavioral or clinical cancer research education, or that involve the development of novel instructional approaches or computer-based tools for cancer research education.
- CREGP–Courses for Skills Development (PAR-15-151): proposed courses may not exceed 15 weeks and should provide innovative, state-of-the-art, evidence-based cancer education that is derived from biomedical, behavioral and clinical cancer research findings, using a traditional in-person approach, online activities, or a hybrid of both approaches.
- CREGP–Research Experiences (PAR-15-152): proposed research experiences should involve an innovative approach to provide hands-on exposure to cancer research in a laboratory or a field setting for a full-time (40 hours per week) period of 10 to 15 weeks to stimulate the interest and advance the knowledge base of participants to consider further education and training for future careers as cancer researchers.
|US Citizens and Foreign Nationals||U.S. citizens and non-U.S. citizen/permanent residents are eligible to apply for this award, provided that the U.S. institution where the candidate spends each phase of the award allows non-U.S. citizens to apply for grant support.|
|Degree/Academic Appointment||Established Investigators at or above the rank of Associate Professor (or equivalent)|
|Commitment||Salary support is allowed; see PAR-15-150, PAR-15-151, or PAR-15-152 for details|
|Duration of Award|
|Citizens, Foreign Nationals and Student Visas||Because this is an educational and not a training mechanism, non-U.S. citizens may participate in this program. However, the participation of non-U.S. citizens should be justified in the application.|
R25 Allowable Costs
|Program PI and Faculty||Salary and fringe benefit support for the design, direction, and implementation of the research education program|
|Administrative Support||Limited administrative and clerical salary costs associated with their work on the program, with justification|
|Other Program-Related Expenses||Consultant costs, equipment, supplies, travel for key persons, and other program-related expenses, with justification|
|Program Participant Costs|
|Direct Costs||Consult PAR-15-150, PAR-15-151, or PAR-15-152 for details|
|F&A Costs/Indirect Costs||8%|
How to Apply
Application Receipt Dates and Review Schedule
|Receipt Cycle||Application Receipt Date: New, Renewal*, Revision*, and Resubmission*||Initial Review||Council Review||Earliest Possible Start Date**|
* Electronic applications have new terminology. The new Grants.gov terminology (included in the table above) corresponds to traditional NIH terms as follows:
- New = New
- Resubmission = Revised or Amended application
- Renewal = Competing Continuation
- Continuation = Progress Report
- Revision = Competing Supplement
If the Application Receipt Date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day and must be submitted by 5:00 PM local time of applicant organization.
** Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Peer Review Process
The Center for Scientific Review (CSR) and the National Cancer Institute (NCI) will review your application for completeness and for conformance to all eligibility requirements and special provisions and requirements. Incomplete applications will be returned to the applicant without further consideration.
If your application is complete and follows all eligibility requirements, then Subcommittee F, convened by the Division of Extramural Activities of the NCI, will evaluate your application according to the review criteria listed in the Program Announcement. Before an award is made, The National Cancer Advisory Board will conduct a second level of review and ensure that your application meets the broad program needs and priorities of the NCI and the National Cancer Program.
For review criteria for the R25 grant mechanism, see the Review Criteria section of the relevant Program Announcement.
- Program Announcements: PAR-15-150, PAR-15-151, PAR-15-152
- Current List of R25 Awards
- Link to Main Peer Review Group NCI-F
- Changes to Public Access Policy Compliance Efforts Notice
- Application Form & Details
NCI Staff Contacts
For additional information regarding policies and/or guidance in preparing an application for the R25 Award, contact:
- Dr. Jeannette Korczak
- Branch Phone: 240-276-5630
For information regarding fiscal and/or budget issues, contact:
- Grants Administration Branch
For information regarding review issues, contact:
- Referral Officer
Division of Extramural Activities